Post-COVID-19 vaccine Guillain-Barre syndrome; first reported case from Qatar.

ABSTRACT:

Introduction

Guillain-Barré syndrome (GBS) is an immune-mediated peripheral neuropathy that was reported following meningococcus, polio, influenza and rabies vaccines. However, an association with the COVID-19 vaccine is yet to be established.

Presentation of case

We present the case of an elderly gentleman with no history of SARS-CoV-2 infection or any recent viral or bacterial illnesses who presented with GBS 20 days after the second dose of COVID-19 vaccination. The diagnosis was established based on physical examination, magnetic resonance imaging (MRI) of the spine, cerebrospinal fluid (CSF) analysis and electromyography (EMG).

Discussion

Due to the occurrence of GBS after certain types of infections, molecular mimicry has become widely acceptable as the underlyi

SUBMITTER: Razok A 

PROVIDER: S-EPMC8253659 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature